INTERCEPT PHARMACEUTICALS

intercept-pharmaceuticals-logo

Intercept Pharmaceuticals is a biopharmaceutical company, that engages in discovering and developing small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases. It offers INT-747, an FXR modulating agent that treats patients with chronic autoimmune liver diseases. The company's drug development programs also focus on modulating bile acid receptors, and amelioration of metabolic and hepatic functions in chronic liver diseases

#People #Financial #Website #More

INTERCEPT PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2002-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.interceptpharma.com

Total Employee:
501+

Status:
Active

Contact:
+1 646 747 1000

Email Addresses:
[email protected]

Total Funding:
567.12 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Wordpress Plugins



Current Advisors List

klaus-veitinger_image

Klaus Veitinger Board Member @ Intercept Pharmaceuticals
Board_member

jonathan-silverstein_image

Jonathan Silverstein Member of the Board of Directors @ Intercept Pharmaceuticals
Board_member

not_available_image

Luca Benatti Member of Independent Board Member @ Intercept Pharmaceuticals
Board_member

srinivas-akkaraju_image

Srinivas Akkaraju Board Member @ Intercept Pharmaceuticals
Board_member

not_available_image

Nicole Williams Board Member @ Intercept Pharmaceuticals
Board_member
2008-01-01

not_available_image

Paolo Fundaro Board Member @ Intercept Pharmaceuticals
Board_member
2006-01-01

chau-khuong_image

Chau Khuong Board of Directors @ Intercept Pharmaceuticals
Board_member

lorenzo-tallarigo_image

Lorenzo Tallarigo Board Member @ Intercept Pharmaceuticals
Board_member
2008-01-01

Current Employees Featured

christian-weyer_image

Christian Weyer
Christian Weyer Executive Vice President of Research & Development @ Intercept Pharmaceuticals
Executive Vice President of Research & Development
2017-11-01

not_available_image

Drew Cronin-Fine
Drew Cronin-Fine Executive Director, US Marketing @ Intercept Pharmaceuticals
Executive Director, US Marketing
2021-10-01

sandip-kapadia_image

Sandip Kapadia
Sandip Kapadia CFO @ Intercept Pharmaceuticals
CFO

mark-pruzanski_image

Mark Pruzanski
Mark Pruzanski Founder, Strategic Advisor and Board Member @ Intercept Pharmaceuticals
Founder, Strategic Advisor and Board Member
2021-01-01

lixia-wang_image

Lixia Wang
Lixia Wang Vice President @ Intercept Pharmaceuticals
Vice President
2019-02-01

david-shapiro_image

David Shapiro
David Shapiro Chief Medical Officer @ Intercept Pharmaceuticals
Chief Medical Officer

gail-cawkwell_image

Gail Cawkwell
Gail Cawkwell Senior Vice President Medical Affairs, Safety, and Pharmacovigalence and Section 16 Officer @ Intercept Pharmaceuticals
Senior Vice President Medical Affairs, Safety, and Pharmacovigalence and Section 16 Officer
2018-02-01

daniel-m-bradbury_image

Daniel M. Bradbury
Daniel M. Bradbury Director @ Intercept Pharmaceuticals
Director
2016-07-01

caroline-stockwell_image

Caroline Stockwell
Caroline Stockwell VP, Head of Legal International @ Intercept Pharmaceuticals
VP, Head of Legal International
2020-10-01

not_available_image

Roberto Pellicciari
Roberto Pellicciari Co-Founder & Head of Medicinal Chemistry @ Intercept Pharmaceuticals
Co-Founder & Head of Medicinal Chemistry

Founder


mark-pruzanski_image

Mark Pruzanski

not_available_image

Roberto Pellicciari

Stock Details


Company's stock symbol is NASDAQ:ICPT

Investors List

aisling-capital_image

Aisling Capital

Aisling Capital investment in Series C - Intercept Pharmaceuticals

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series C - Intercept Pharmaceuticals

genextra_image

Genextra

Genextra investment in Series B - Intercept Pharmaceuticals

genextra_image

Genextra

Genextra investment in Series A - Intercept Pharmaceuticals

jafco-life-science_image

Jafco Life Science

Jafco Life Science investment in Venture Round - Intercept Pharmaceuticals

genextra_image

Genextra

Genextra investment in Venture Round - Intercept Pharmaceuticals

balyasny-asset-management_image

Balyasny Asset Management

Balyasny Asset Management investment in Venture Round - Intercept Pharmaceuticals

rodman-renshaw_image

Rodman & Renshaw

Rodman & Renshaw investment in Debt Financing - Intercept Pharmaceuticals

Official Site Inspections

http://www.interceptpharma.com Semrush global rank: 3.44 M Semrush visits lastest month: 4.45 K

  • Host name: server-3-168-122-116.jfk52.r.cloudfront.net
  • IP address: 3.168.122.116
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Intercept Pharmaceuticals"

About Us - Intercept Pharmaceuticals

YOU ARE NOW leaving interceptpharma.com. The link you have selected will take you outside of Intercept Pharmaceuticals’ corporate website. The site you will be entering is intended for U.S. audiences only. Continue. If you are a …See details»

Leadership - Intercept Pharmaceuticals

Sangeeta Sawhney, M.D. serves as our Senior Vice President, Head of U.S. Research and Development and has been part of Intercept since 2021. Sangeeta brings 20+ years of combined clinical and drug development experience …See details»

Intercept Pharmaceuticals - Wikipedia

40°40′43″N 78°14′35″W / 40.678631°N 78.243038°W Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease (or non-alcoholic steatohepatitisSee details»

Intercept Pharmaceuticals - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number +1 646 747 1000 Intercept Pharmaceuticals is a biopharmaceutical company, that engages in discovering and developing …See details»

Intercept Pharmaceuticals Company Profile | Management and

SQL International Organization for Standardization . CSS World Wide Web Consortium . Web Analytics (5 Technologies) Google Global Site Tag Google . ... [email protected]: …See details»

Intercept Pharmaceuticals - AnnualReports.com

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, including primary biliary cholangitis (PBC), nonalcoholic …See details»

Intercept Pharmaceuticals, Inc. (ICPT) Company Profile & Overview ...

Oct 11, 2012 It markets its products through an internal commercial organization and third-party distributors. The company was incorporated in 2002 and is headquartered in Morristown, New …See details»

Intercept Pharmaceuticals - LinkedIn

Intercept Pharmaceuticals | 64,797 followers on LinkedIn. Our mission is to build a healthier tomorrow for patients with rare and serious liver diseases. | We are a biopharmaceutical …See details»

Intercept Pharmaceuticals

Nov 21, 2024 The company has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. It markets its products through …See details»

Intercept Pharmaceuticals - Overview, News & Similar ... - ZoomInfo

Jun 16, 2024 Explore Complete Organization Structure. Is Intercept Pharmaceuticals your ideal customer? Let us give you the heads up on whether it's a good time to reach out ... (646) 747 …See details»

Intercept Pharmaceuticals Information - RocketReach

We are committed to improving patients’ lives and addressing the liver community’s most pressing needs. Our corporate headquarters is located in New Jersey. For more information about …See details»

Intercept Pharmaceuticals Company Overview, Contact Details ...

Jun 30, 2016 For more information about Intercept, please visit our website at: www.interceptpharma.com and follow us on X at: @InterceptPharma. Sign up for free to view …See details»

Intercept Pharmaceuticals Company Profile: , Investments, Contact ...

We are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, including primary biliary cholangitis …See details»

Intercept Pharmaceuticals - Craft

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary …See details»

Culture - Intercept Pharmaceuticals

Entrepreneurial spirit Intercept started as a vision in our founder’s small New York City apartment, and we’ve never lost our entrepreneurial spirit. We’re now a more than 300-person team with a …See details»

Intercept Pharmaceuticals

Letter of Request on organization’s letterhead; Program agenda / brochure; Completed W-9 Form; Submit all completed documents to [email protected]; Education Grants may be …See details»

Intercept Pharmaceuticals, Inc. Company Information - Drugs.com

Aug 31, 2015 Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided …See details»

Working at Intercept Pharmaceuticals - Zippia

Www.interceptpharma.com. Organization Type. Public. CEO. Jerome B. Durso. Social Media. Intercept Pharmaceuticals focuses on developing solutions to treat progressive non-viral liver …See details»

News - Intercept Pharmaceuticals

Jun 5, 2024 YOU ARE NOW leaving interceptpharma.com. The link you have selected will take you outside of Intercept Pharmaceuticals’ corporate website. The site you will be entering is …See details»

linkstock.net © 2022. All rights reserved